Stereoselective behavior of a novel biodegradable racemic ketoprofen injectable implant in rats

Chirality

Volumn 19, Issue 10, 2007, Pages 769-774

  Wang, Sheng Hao ^a,b   Yin, Li Na ^b   Liang, Ze Hua ^c   Lu, Si Jie ^a   Zeng, Su ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Biodegradable injectable implant; Ketoprofen enantiomer; Pre column chiral derivatization; RP HPLC; Stereoselectivity

Indexed keywords

1 ETHYL 2 PYRROLIDONE; 2 PYRROLIDONE DERIVATIVE; KETOPROFEN; N-ETHYL-2-PYRROLIDONE; POLYESTER; POLYLACTIDE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIODEGRADABLE IMPLANT; CHEMISTRY; DRUG IMPLANT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; RAT; SPRAGUE DAWLEY RAT; STEREOISOMERISM; SUBCUTANEOUS DRUG ADMINISTRATION;

ABSORBABLE IMPLANTS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG IMPLANTS; INJECTIONS, SUBCUTANEOUS; KETOPROFEN; POLYESTERS; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM;

EID: 38449098545     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.20453     Document Type: Article

References (27)

1. Siewert M, Dressman J, Brown CK, Shah VP. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS Pharm Sci Tech 2003;4:E7.
2. Duddu SP, Vakilynejad M, Jamali F. Stereoselective dissolution of propranolol hydrochloride from hydroxypropylmethylcellulose matrices. Pharm Res 1993;10: 1648-1653.
3. Vakily M, Jamali F. Human pharmacokinetics of tiaprofenic acid after regular and sustained release formulations: lack of chiral inversion and stereoselective release. J Pharm Sci 1994;83: 495-498.
4. Vakily M, Pasutto FM, Daneshtalab M, Jamali F. Inclusion complexation of heptakis(2,6-di-ethyl)-b-cyclodextrin with tiaprofenic acid: pharmacokinetic consequences of a pH-dependent release and stereoselective dissolution. J Pharm Sci 1995;84: 1014-1019.
5. Janjikhel PK. Stereospecific formulation and characterization of sustained release ibuprofen microspheres. J Microencapsul 1997;14: 409-426.
6. Qiu Y, Hui HW, Cheskin H. Formulation development of sustainedrelease hydrophilic matrix tablets of zileuton. Pharm Dev Technol 1997;2: 197-204.
7. Solinis MA, Lugara S, Calvo B, Hernandez RM, Gascon AR, Pedraz JL. Release of salbutamol sulfate enantiomers from hydroxypropylmethylcellulose matrices. Int J Pharm 1998;16: 37-43.
8. Solinis MA, Cruz Y, Calvo B, Hernandez RM, Gascon AR, Goni I, Gurruchaga MD, Pedraz JL. Release of salbutanmol sulphate and ketoprofen enantiomers from matrices containing HPMC and cellulose derivatives. Chirality 2002;4: 806-813.
9. Solinis MA, Cruz Y, Hernandez RM, Gascon AR, Calvo B, Pedraz JL. Release of ketoprofen enantiomers from HPMC K100M matrices - diffusion studies. Int J Pharm 2002;239: 61-68.
10. Alvarez C, Torrado JJ, Cadorniga R. Stereoselective drug release from ketoprofen and ricobendazole matrix tablets. Chirality 1999;11: 611-615.
11. Janjikhel RK, Adeyeye CM. Dissolution of ibuprofen enantiomers from coprecipitates and suspensions containing chiral excipients. Pharm Dev Technol 1999;4: 9-17.
12. Suedee R, Srichana T, Chotivatesin R. Enantioselective release of controlled delivery granules based on molecularly imprinted polymers. Drug Deliv 2002;9: 19-30.
13. Wang SH, Zeng S. Stereorelease of enantiomers from chiral formulation. Chin Pharm J 2005;40: 10-12.
14. Simo C, Gallardo A, Parejo C, San Roman J, Barbas C, Cifuentes A. Monitoring ibuprofen enantiomers released from polymeric systems. Eur J Pharm Sci 2002;16: 75-82.
15. Wang SH, Zhang LC, Lin F, Sa XY, Zuo JB, Shao QX, Chen GS, Zeng S. Controlled release of levonorgestrel from biodegradable poly(D,Llactide- co-glycolide) microspheres: in vitro and in vivo studies. Int J Pharm 2005;301: 217-225.
16. Park TG. Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. Biomaterials 1995;16: 1123-1130.
17. Onishi H, Takahashi M, Machida Y. PLGA implant tablet of ketoprofen: comparison of in vitro and in vivo releases. Biol Pharm Bull 2005;28: 2011-2015.
18. Dunn RL, Tipton AJ, Southard GL, Rogers JA. US Patent 5,077,049, 1989.
19. Shah NH, Railkar AS, Chen FC, Tarantino R, Kumar S, Murjani M, Palmer D, Infeld MH, Malick AW. A biodegradable injectable implant for delivering micro and macromolecules using poly(lactic-co-glycolic acid) (PLGA) copolymer. J Controlled Release 1993;27: 139-147.
20. Eliaz RE, Wallach D, Kost J. Delivery of soluble tumor necrosis factor receptor from in-situ forming PLGA implant: in-vivo. Pharm Res 2000;17: 1546-1550.
21. Wang SH, Liang ZH, Zeng S. Monitoring release of ketoprofen enantiomers from biodegradable poly(D,L-lactide-co-glycolide) injectable implants. Int J Pharm 2007;337: 102-108.
22. Hutt AJ, Fournel S, Caldwell J. Application of a radial compression column to the high-performance liquid chromatographic separation of the enantiomers of some 2-arylpropionic acids as their diastereoisomeric S-(2)-1-(naphthen-1-yl)ethylamines. J Chromatogr 1986;378: 409-418.
23. Populaire P, Terlain B, Pascal S, Decouvelaere B, Renard A, Thanas JP. Biological behavior: Serum levels, excretion and biotransformation of (3-benzoylphenyl)-2-propionic acid, or ketoprofen, in animals and men. Ann Pharm Fr 1973;31: 735-749.
24. Iwakawa S, He X, Hashimoto S, Volland C, Benet LZ, Lin ET. Stereoselective disposition of ketoprofen in rats. Drug Metab Dispos 1991;19: 717-718.
25. Yasui H, Yamaoka K, Dote N, Nakagawa T. Moment analysis of stereoselective biliary excretion and chiral inversion of ketoprofen enantiomers in perfused rat liver. J Pharm Sci 1995;84: 1327-1331.
26. Chen CC, Chueh JY, Tseng H, Huang HM, Lee SY. Preparation and characterization of biodegradable PLA polymeric blends. Biomaterials 2003;24: 1167-1173.
27. Mauleon D, Artigas R, Garcia ML, Carganico G. Preclinical and clinical development of dexketoprofen. Drugs 1996;52: 21-45